v3.22.2.2
Stock-based Compensation (Tables)
9 Months Ended
Oct. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Classification of Stock-based Compensation

The following table presents the classification of stock-based compensation for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

360

 

 

$

391

 

 

$

1,071

 

 

$

1,073

 

Research and development

 

 

18,741

 

 

 

13,725

 

 

 

53,775

 

 

 

36,444

 

Selling, general and administrative

 

 

9,000

 

 

 

7,937

 

 

 

27,205

 

 

 

22,750

 

Total stock-based compensation

 

$

28,101

 

 

$

22,053

 

 

$

82,051

 

 

$

60,267

 

Weighted-Average Assumptions Used to Estimate Fair Value

The following table sets forth the weighted-average assumptions used to estimate the fair value of stock options and employee stock purchase plan awards for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Stock Options:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

 

 

 

 

 

 

 

 

 

51

%

Risk-free interest rate

 

 

 

 

 

 

 

 

 

 

 

0.98

%

Expected term (years)

 

 

 

 

 

 

 

 

 

 

5.27

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

0

%

Employee stock purchase plan awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

72

%

 

 

54

%

 

 

81

%

 

 

57

%

Risk-free interest rate

 

 

3.78

%

 

 

0.05

%

 

 

2.32

%

 

 

0.06

%

Expected term (years)

 

0.5

 

 

0.5

 

 

0.5

 

 

0.5

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

 

Stock Option Activities

The following table summarizes stock option activities for the period indicated:

 

 

 

Option Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Intrinsic

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Value Of

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

 

Options

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

 

Average

 

 

Grant-date

 

 

Exercised

 

 

Term

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Fair Value

 

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 31, 2022

 

 

619,322

 

 

$

40.08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(79,880

)

 

 

30.79

 

 

 

 

 

 

$

4,696

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(7,995

)

 

 

49.19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(1,418

)

 

 

19.81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at October 31, 2022

 

 

530,029

 

 

 

41.40

 

 

 

 

 

 

 

 

 

 

4.42

 

 

$

8,605

 

Exercisable at October 31, 2022

 

 

392,266

 

 

$

43.51

 

 

 

 

 

 

 

 

 

 

 

3.47

 

 

$

5,417

 

Restricted Stock Unit Activities

The following table summarizes restricted stock unit activities for the period indicated:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at January 31, 2022

 

 

2,651,135

 

 

$

85.41

 

Granted

 

 

1,499,374

 

 

 

74.42

 

Vested

 

 

(1,258,895

)

 

 

69.81

 

Forfeited

 

 

(77,346

)

 

 

101.36

 

Unvested at October 31, 2022

 

 

2,814,268

 

 

$

86.40